⌘K
t
OptiBiotix Health plc announced on 8 August 2024 that its Annual General Meeting (AGM) was held earlier today. At the AGM, all resolutions were duly passed.
| Date | 8 Aug 2024 |
| Time | 12:29:24 |
| Category | AGMs and other meetings |
| ID | 7693Z |
8 August 2024
OptiBiotix Health plc
("OptiBiotix" or the "Company" or the "Group")
Result of AGM
OptiBiotix Health plc (AIM: OPTI), a life sciences business developing compounds to tackle obesity, high cholesterol, diabetes and skin care announces that at the AGM held earlier today, all resolutions were duly passed.
The full voting results will be available on the website in due course here: https://www.optibiotix-ir.com/content/investors/
For further information, please contact:
|
OptiBiotix Health plc |
||
|
Neil Davidson, Chairman |
Contact via Walbrook below |
|
|
Stephen O'Hara, Chief Executive |
|
|
|
|
|
|
|
Cairn Financial Advisers LLP (NOMAD) |
Tel: 020 7213 0880 |
|
|
Liam Murray / Jo Turner / Ludovico Lazzaretti
|
|
|
|
Peterhouse Capital Limited (Broker) |
Tel: 020 7220 9797 |
|
|
Duncan Vasey / Lucy Williams |
|
|
|
|
|
|
|
Walbrook PR Ltd |
Mob: 07876 741 001 |
|
|
Anna Dunphy |
|
|
About OptiBiotix - www.optibiotix.com
OptiBiotix Health plc (AIM: OPTI), which was formed in March 2012, brings science to the development of compounds which modify the human microbiome - the collective genome of the microbes in the body - in order to prevent and manage human disease and promote wellness.
OptiBiotix has an extensive R&D programme working with leading academics in the development of microbial strains, compounds, and formulations which are used as active ingredients and supplements. More than twenty international food and healthcare supplement companies have signed agreements with OptiBiotix to incorporate their human microbiome modulators into a wide range of food products and drinks.
OptiBiotix is also developing its own range of consumer supplements and health products. The Company's current areas of focus include obesity, cardiovascular health, and diabetes.